ArticleBMC endocrine disorders2025
Predictive value of MetS-IR for the glucose status conversion in prediabetes: a multi-center retrospective cohort study.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between GLM7 glycolipid metabolism index and female infertility: A cross-sectional analysis of NHANES 2013-2020.Medicine · 2026Article
- Beyond HOMA-IR: Comparative Evaluation of Insulin Resistance and Anthropometric Indices Across Prediabetes and Type 2 Diabetes Mellitus in Metabolic Syndrome Patients.Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe metabolic score for insulin resistance (METS-IR), a surrogate parameter for insulin resistance, is closely correlated with glucose metabolism. This study aims to investigate the impact of METS-IR in the progression from prediabetes to diabetes, as well as the reversion to normoglycemia in individuals with prediabetes.
methodsThis retrospective cohort study comprised 15,424 prediabetes patients from 32 sites across 11 cities in China. We monitored changes in the glycemic status of these patients over the follow-up period, including the reversion from prediabetes to normoglycemia, progression to diabetes, or maintenance of the prediabetic condition. Cox proportional hazard regression analysis and restricted cubic splines (RCS) were conducted to investigate the correlation between METS-IR and the progression to diabetes or reversion to normoglycemia. Additionally, the predictive value of MetS-IR for changes in glucose status was evaluated using receiver operating characteristic (ROC) curve analysis.
resultsDuring the median follow-up of 2.92 years, 6682 individuals (43.3%) reverted from prediabetes to normoglycemia, 6992 individuals (45.3%) remained in prediabetes status, and 1750 individuals (11.3%) progressed to diabetes. Notably, an increase in the baseline METS-IR quartile was associated with a heightened risk of diabetes development and a reduced likelihood of reverting to normoglycemia (both P for trend < 0.001). Multivariate Cox regression and RCS analysis showed that METS-IR was significantly associated with both the progression to diabetes and the reversion to normoglycemia, exhibiting a non-linear relationship in both cases. Compared with the lowest METS-IR quartile, the adjusted hazard ratio (HR) (95% confidence interval [CI]) for diabetes progression and normoglycemic reversion in the highest METS-IR quartile was 2.11 (1.78, 2.50) and 0.57 (0.53, 0.62), respectively. The ROC curves analysis showed that METS-IR was the most effective predictor of glycemic status transition in individuals with prediabetes, with an area under the curve (AUC) surpassing those of triglyceride glucose (TyG), atherogenic index of plasma (AIP), and body mass index (BMI).
conclusionOur study reveals a significant correlation between METS-IR and prediabetes reversion/progression. Regular monitoring of METS-IR in clinical practice may help predict the conversion of glucose status in prediabetes patients and enhance the early identification of populations at elevated risk for diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.